Atrovent hfa and Swelling face - a phase IV clinical study of FDA data

Summary:

Swelling face is reported as a side effect among people who take Atrovent hfa (ipratropium bromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Bronchitis.

The phase IV clinical study analyzes which people have Swelling face when taking Atrovent hfa. It is created by eHealthMe based on reports of 2,391 people who have side effects when taking Atrovent hfa from the FDA, and is updated regularly.

What is Atrovent hfa?

Atrovent hfa has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 2,440 Atrovent hfa users. Check the latest studies of Atrovent hfa.

What is Swelling face?

Swelling face is found to be associated with 1,900 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Swelling face.

On Jul, 11, 2026

2,391 people reported to have side effects when taking Atrovent hfa.
Among them, 11 people (0.46%) have Swelling face.

Among these 11 people:

How long have people been on Atrovent hfa when they have Swelling face? *

What is the gender of people who have Swelling face when taking Atrovent hfa? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Swelling face when taking Atrovent hfa? *

What are other drugs people take besides Atrovent hfa? *

What are other side effects people have besides Swelling face? *

Rashes (redness): 7 people, 63.64%
Dyspnea (difficult or laboured breathing): 3 people, 27.27%
Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 18.18%
Nausea (feeling of having an urge to vomit): 2 people, 18.18%
Diarrhea: 1 person, 9.09%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 9.09%
Arrhythmias (irregular heartbeat): 1 person, 9.09%
Balance Disorder: 1 person, 9.09%
Blood Creatinine Increased: 1 person, 9.09%
Chronic Hepatic Failure (long lasting liver failure): 1 person, 9.09%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 27.27%
Dyspnea (difficult or laboured breathing): 3 people, 27.27%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 27.27%
Pulmonary Congestion (congestion in the lungs): 2 people, 18.18%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 9.09%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 9.09%
Pruritus Allergic (severe allergic itching of the skin): 1 person, 9.09%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 9.09%
Pain: 1 person, 9.09%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent hfa and have Swelling face?

- Check whether Swelling face is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atrovent hfa:

Atrovent hfa (2,440 reports)

Swelling face treatments and more:

Swelling face (70,017 reports)

Browse all side effects of Atrovent hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling face:

Swelling face (1,900 drugs)

Browse all the conditions that are associated with Swelling face:

Swelling face (2,206 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide (the active ingredients of Atrovent hfa) and Atrovent hfa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.